<DOC>
	<DOCNO>NCT00004199</DOCNO>
	<brief_summary>RATIONALE : Prinomastat may stop growth non-small cell lung cancer stop blood flow tumor . Drugs use chemotherapy stop tumor cell divide stop grow die . PURPOSE : Randomized phase III trial determine effectiveness prinomastat plus cisplatin gemcitabine treat patient metastatic recurrent non-small cell lung cancer .</brief_summary>
	<brief_title>Prinomastat Combination Chemotherapy Treating Patients With Metastatic Recurrent Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare overall survival , progression free survival , symptomatic progression free survival , one year survival patient metastatic recurrent non-small cell lung cancer treat prinomastat ( AG3340 ) placebo combination gemcitabine cisplatin . II . Compare disease response duration response patient regimens . III . Compare quality life patient regimens . IV . Evaluate safety regimens patient . OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients receive oral prinomastat placebo twice daily begin day 1 , follow gemcitabine IV day 1 8 cisplatin IV day 1 . Courses repeat every 3 week . PROJECTED ACCRUAL : Approximately 420 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Prinomastat</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Stage IV recurrent T4 lesion nonsmall cell lung cancer Measurable evaluable disease No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy nonsmall cell lung cancer Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>